The Business Opportunity

The assessment of a patient’s pain level is critical to ensure the effectiveness of on-going care. Various studies suggest that using valid and reliable pain-monitoring systems can minimize the use of sedative and analgesic drugs; decrease the patient’s recovery time, lessen the risk of side effects, and reduce direct and indirect costs. Currently, pain level is monitored based on the patient’s subjective statement, if the patient can communicate, or based on physician’s estimation, if the patient cannot communicate.

The technologies used for pain measurement today are based on brain imaging (fMRI), which due to its high cost (millions of dollars for MRI, and hundreds of dollars per test), long duration, and sensitivity to movement is used mainly for diagnosis or research purposes but not for ongoing monitoring. Therefore, there is a need for a low cost and continuous monitoring system with an objective scale for determining and tracking the pain level.

Medasense’s technology enables continuous measuring of the pain level with the same ease and cost as other patient monitors (ECG, SPO2, capnograph, awareness). The unique combination of multiple non-invasive sensors with state-of-the-art algorithms enables the device to monitor pain at any time and with any procedure.

News

September, 2011:
Medasense Biometrics chosen to present at the 8th Annual Israel Strategic Partner and Venture Conference on September 22, 2011

September, 2011:
Results of Medasense supported research were presented at "Pain in Europe VII", the 7th Congress of the European Federation of International Association for the Study of Pain Chapters

August, 2011:
Medasense Biometrics technology is featured in a newspaper article “Feel its pain: why the healthcare system doesn’t have a standard for measuring pain?” by Gali Weinreb, Globes, August 27th, 2011

June, 2011:
Medasense Biometrics has appeared on "The Landes Shortlist of Promising Israeli Technologies", by C. Wylie, Cell Cycle, Vol. 10, pp. 1887-1881.

May 2011:
Medasense to present at ILSI- Biomed Israel 2011 (Monday, May 23, 18:10 – 18:30)

December 2010:
OHV and Dr. Shmuel Cabilly invest in Medasense Biometrics

November 2010:
Results of Medasense supported research were presented on the annual conference of the Israel Pain Association

June 2010:
Medasense to present at Personalized Medicine World Conference 2010 Israel

December 2008:
Capital Point invests in Medasense Biometrics